Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.
| Image |  |
|---|---|
| Description | scientific article published on 28 November 2017 |
| Author/s |
author: Luca Arcaini Stefano A Pileri David Belada José Cabeçadas Tsvetan Biyukov Thierry Lamy Julia Alexeeva Simon A Rule Franck Morschhauser John Radford Meera Patturajan Jan Walewski Wojciech Jurczak Elías Campo Marie-Laure Casadebaig Bravo |
| Publication date | November 28, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |